Mice lacking pituitary tumor transforming gene show testicular and splenic hypoplasia, thymic hyperplasia, thrombocytopenia, aberrant cell cycle progression, and premature centromere division - PubMed (original) (raw)
Mice lacking pituitary tumor transforming gene show testicular and splenic hypoplasia, thymic hyperplasia, thrombocytopenia, aberrant cell cycle progression, and premature centromere division
Z Wang et al. Mol Endocrinol. 2001 Nov.
Abstract
Tumorigenic pituitary tumor transforming gene (PTTG) is a mammalian homolog of Xenopus securin that inhibits chromatid separation, is overexpressed in many human tumor types, and mediates transcriptional activation. Loss of yeast securin Pds1p or Drosophila securin pimples is lethal. Here we show that mice lacking PTTG (PTTG -/-) are, surprisingly, viable and fertile; but they have testicular and splenic hypoplasia, thymic hyperplasia, and thrombocytopenia. PTTG -/- mouse embryo fibroblasts exhibited aberrant cell cycle progression with prolonged G2-M phase and binucleated and multinucleated nuclei with increased aneuploidy. PTTG -/- mouse embryo fibroblast metaphases contained quadriradial, triradial, and chromosome breaks, as well as premature centromere division. The results show that PTTG functions to maintain chromosome stability, cell cycle progression, and appropriate cell division. Moreover, mammalian sister chromatid separation, an important transition in the cell cycle, is likely regulated by mechanisms in addition to securin.
Similar articles
- Discordant proliferation and differentiation in pituitary tumor-transforming gene-null bone marrow stem cells.
Rubinek T, Chesnokova V, Wolf I, Wawrowsky K, Vlotides G, Melmed S. Rubinek T, et al. Am J Physiol Cell Physiol. 2007 Sep;293(3):C1082-92. doi: 10.1152/ajpcell.00145.2007. Epub 2007 Jul 11. Am J Physiol Cell Physiol. 2007. PMID: 17626243 - Pituitary tumor transforming gene (PTTG) regulates placental JEG-3 cell division and survival: evidence from live cell imaging.
Yu R, Ren SG, Horwitz GA, Wang Z, Melmed S. Yu R, et al. Mol Endocrinol. 2000 Aug;14(8):1137-46. doi: 10.1210/mend.14.8.0501. Mol Endocrinol. 2000. PMID: 10935539 - Murine pituitary tumor-transforming gene functions as a securin protein in insulin-secreting cells.
Yu R, Cruz-Soto M, Li Calzi S, Hui H, Melmed S. Yu R, et al. J Endocrinol. 2006 Oct;191(1):45-53. doi: 10.1677/joe.1.06885. J Endocrinol. 2006. PMID: 17065388 - Pituitary tumor-transforming gene in endocrine and other neoplasms: a review and update.
Salehi F, Kovacs K, Scheithauer BW, Lloyd RV, Cusimano M. Salehi F, et al. Endocr Relat Cancer. 2008 Sep;15(3):721-43. doi: 10.1677/ERC-08-0012. Endocr Relat Cancer. 2008. PMID: 18753362 Review. - The emerging role of pituitary tumor transforming gene in tumorigenesis.
Tfelt-Hansen J, Kanuparthi D, Chattopadhyay N. Tfelt-Hansen J, et al. Clin Med Res. 2006 Jun;4(2):130-7. doi: 10.3121/cmr.4.2.130. Clin Med Res. 2006. PMID: 16809406 Free PMC article. Review.
Cited by
- Pituitary tumor‑transforming gene 1 regulates the senescence and apoptosis of oral squamous cell carcinoma in a p21‑dependent DNA damage response manner.
Park S, Kim S, Kim MY, Lee SS, Choi J. Park S, et al. Oncol Rep. 2024 Oct;52(4):135. doi: 10.3892/or.2024.8794. Epub 2024 Aug 19. Oncol Rep. 2024. PMID: 39155881 Free PMC article. - The two sides of chromosomal instability: drivers and brakes in cancer.
Hosea R, Hillary S, Naqvi S, Wu S, Kasim V. Hosea R, et al. Signal Transduct Target Ther. 2024 Mar 29;9(1):75. doi: 10.1038/s41392-024-01767-7. Signal Transduct Target Ther. 2024. PMID: 38553459 Free PMC article. Review. - Cancer-associated fibroblasts in gynecological malignancies: are they really allies of the enemy?
Villegas-Pineda JC, Ramírez-de-Arellano A, Bueno-Urquiza LJ, Lizarazo-Taborda MDR, Pereira-Suárez AL. Villegas-Pineda JC, et al. Front Oncol. 2023 Apr 24;13:1106757. doi: 10.3389/fonc.2023.1106757. eCollection 2023. Front Oncol. 2023. PMID: 37168385 Free PMC article. Review. - Separase and Roads to Disengage Sister Chromatids during Anaphase.
Konecna M, Abbasi Sani S, Anger M. Konecna M, et al. Int J Mol Sci. 2023 Feb 27;24(5):4604. doi: 10.3390/ijms24054604. Int J Mol Sci. 2023. PMID: 36902034 Free PMC article. Review. - Elevated PTTG1 predicts poor prognosis in kidney renal clear cell carcinoma and correlates with immunity.
Zhang X, Ji H, Huang Y, Zhu B, Xing Q. Zhang X, et al. Heliyon. 2023 Jan 24;9(2):e13201. doi: 10.1016/j.heliyon.2023.e13201. eCollection 2023 Feb. Heliyon. 2023. PMID: 36793955 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases